WHO list of prequalified in vitro diagnostic products updated
IVD
News
Revised Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases published
M
The 20th Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases, is published with the following changes:
A) The following products
Hetero’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two PQT Medicines trainings for regulators in 2022
M
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.
Zhejiang Apeloa’s levofloxacin tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Suspension of supply of COVID-19 vaccine (COVAXIN®)
V
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
COVID-19 PANDEMIC AND EMERGENCY USE LISTING
IVD
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing.
Remdesivir added to COVID-19 Invitation for Expression of Interest (EOI)
M
Remdesivir invited for COVID-19:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
First entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First levonorgestrel intrauterine delivery system (IUS) prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
PRESENTATIONS AVAILABLE - Joint UNICEF‒UNFPA‒WHO Meeting for Manufacturers and Suppliers
ID
IVD
IS
M
V
VCP
Presentations of the Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 08 to 10 March 2022 are now available on the following page:
MSN Labs’ darunavir tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: